She lost 132 lb in a tirzepatide trial. Then they took the drug away.

Tara Rothenhoefer was one of the first people to try tirzepatide before it had a name. Eighteen months and 132 lb later, the trial ended with no medication, no follow-up, and no idea what came next.

One Of The First Tirzepatide Trial Patients: Six Years and 220lbs Down on GLP- 1

Tara Rothenhoefer weighed 342 lb when she walked into a clinical trial office in March 2020. She had a one in four chance of getting the real drug. The other 75 percent would get a placebo.

She got the real thing. Eighteen months later, she had lost 132 lb. Then the trial ended. They weighed her one last time, sent her home with no medication, no follow-up, and never contacted her again.

This was before Mounjaro had a name. Before compounded tirzepatide existed. Before there was any guarantee she would ever get it again.

I didn't know if I was ever going to get it again. I felt like I have never really had any sort of addiction, but I imagine that's what it feels like.GLP-1 Hub

1. Her sister died from obesity complications at 400 lb

Tara had been battling obesity since she was nine or ten years old. She started Weight Watchers at 12. For the next 35 years, she did everything: lost 40 lb and gained 60, lost 50 and gained 80. The cycle never stopped.

In December 2018, her oldest sister died from complications of obesity. She was a mom and a grandma. Tara heard people say it was a shame she couldn't get herself together, get herself under control.

That hit differently. Tara was nearly 400 lb herself. She thought about it as a character flaw, a lack of willpower. She could do everything else in life. Why not this?

When she heard the radio ad for a weight loss medication trial in March 2020, she called. They told her they were full. Her husband called too, got a screening spot, then was disqualified because the trial discovered he was diabetic.

Tara called back the next morning. The nutritionist said she had a waiting list but asked if Tara could come in the next day. Tara told her she would be on the doorstep when they opened. She was.

I was already in a life or death situation. At my heaviest, I weighed almost 400 lb. How long was I going to be able to go on like that?GLP-1 Hub

Why this matters if you haven’t started yet: If you have tried every diet and felt like a failure, Tara's story may sound familiar. The trial gave her something she had never had: hope that this time could be different.

2. She started at 5 mg, no titration, no 2.5 mg dose

The trial was called Surmount Phase 1. Tara later found out they started participants at 5 mg, then moved to 10 mg, then 15 mg. No transitions. No 2.5 mg dose.

She never saw 2.5 mg. When Mounjaro launched commercially, it started everyone at 2.5. Tara's trial did not.

Before her first injection, the trial team did weeks of testing: blood work, EKGs, complete medical and mental health background. She felt they did their due diligence.

The first injection happened in the office. They watched her do it. After that, she got the box for the rest of the month and recorded where and when she injected. About six months in, they started giving her three months at a time.

Why this matters if you haven’t started yet: The trial protocol was different from what doctors prescribe today. If you are starting Mounjaro or Zepbound now, you will begin at 2.5 mg and titrate up slowly.

3. Day three, the food noise turned off like a switch

Tara woke up the day after her first injection expecting angels to sing. She felt completely the same. Day two, same. She still wanted food, still thought about food, still had no self-control around donuts.

On day three, she was sitting at her desk working. She looked at the clock. It was 11:40 a.m. She realized she had not eaten breakfast and was not even thinking about lunch yet.

She got up, walked to a coworker's office, and said, I am not thinking about food. She had not had even the slightest thought of food all day.

She describes it as walking to a switch and turning it off. That was the moment she felt normal for the first time. She did not know what feeling normal meant until the noise was gone.

It was the first time she did not feel like a failure, did not beat herself up for being unable to control something everyone told her she should be able to control.

I didn't know what feeling normal meant or what I even thought feeling normal meant. But in that moment, I felt normal.GLP-1 Hub

4. She lost 20 lb the first month, 70 lb in six months

Tara lost 20 lb in the first month. That made her want to do more to help herself, to help the medication work. The more weight she lost, the more she wanted to be an active participant.

She lost 70 lb in the first six months. The nutritionist told her she probably had the best reaction of anyone in their group.

Tara moved from walking to riding a bike to going to the gym. She tried swimming. She started researching healthy foods, eating things she had never tried before. She hates to cook and is not good at it, but she made the effort.

She gives herself credit for using the medication as a tool, not a crutch or a magic pill. She was an active participant in her own journey.

Why this matters if you haven’t started yet: The trial included lifestyle support. The nutritionist told Tara to move her body as soon as she felt able, even if that was just walking to the end of the driveway and back.

5. Her only side effect was a migraine for a week straight

In the first month, Tara had a pounding migraine for a solid week. Nothing touched it. She thought maybe it was from eating less sugar or fewer carbs.

The trial team told her that was not really a side effect of the medication. They marked it down in her chart. It is now listed as a known side effect.

She also experienced constipation pretty much the entire time. She learned to manage it with over-the-counter remedies and never needed a prescription. It caused her discomfort for a day or two but never sent her to the hospital.

6. The trial ended, the weight came back, and the noise got louder

Tara lost 132 lb in 18 months. She got down to about 210 lb. She was disappointed she did not get under 200 but confident she could do it on her own.

She did. Three or four months after the trial ended, she got to Onederland with no medication. She was still doing all the things she had learned.

But slowly the noise came back. It was dull, then louder, then more persistent. She felt like she had a devil and an angel sitting on her shoulders: do not eat that, you have to eat that.

She was not eating the way she did before. She was drinking water, exercising, eating what she thought normal people eat. Maybe two Oreos at night sometimes, not every day. A piece of pizza or a slice of birthday cake at a party.

The weight was coming back on. In the year between when the trial ended and the medication became available by prescription, she gained 12 to 15 lb.

She saw the writing on the wall. It would be 15 lb every year until she was back where she started. She was still eating right, still exercising, still drinking water. Her rings were getting tighter. Her ankles started to swell. The inflammation was coming back.

I was doing all the things. I'm drinking the water. I'm doing the exercise. I'm eating what normal people do, but yet I was gaining weight.GLP-1 Hub

7. Her cystic acne came back when the medication stopped

Tara had cystic acne her entire adult life. She went to dermatologists, tried everything over the counter, took antibiotics. Nothing helped.

On the medication, it completely cleared up. She did not connect it to the trial until it started coming back when she was off the medication.

Then she started hearing about PCOS, Hashimoto's, perimenopause, menopause. She realized the medication touched so much more than food noise and weight. It was controlling inflammation and things she did not even know it was treating.

8. She got back on medication and faced shortages and judgment

As soon as tirzepatide was approved, Tara called her doctor. He was conservative and only prescribed it for diabetes, so she went through a telehealth company for brand name medication.

She was one of the lucky ones to get on the original savings card for $25 a month. But nobody had the medication in stock. She would call pharmacies hours away to see if they had it.

The look she got at the pharmacy was crushing. People looked at her like she did not need it. She was not diabetic, not obese anymore. The judgment made her sometimes not want to go get it. If there was a line, she would get out and wait.

This was the beginning of the narrative that she was taking her grandma's diabetes medication and grandma was going to die because of her. It was bizarre. She would pray every month and beg the doctor to call in a three month supply.

She did not care about the milk or the food if her power went out. She cared about the medication. Looking back, she can laugh about it now, but it was real life. Nothing like she had ever felt before.

Why this matters if you haven’t started yet: The shortage era was brutal. If you are starting now, you are entering a different landscape, but access is still not guaranteed for everyone.

9. She got down to 119 lb and her body was not okay

Tara kept losing. At the start of the trial, all she wanted was to be under 300 lb. Then under 200. Then 175, which she thought was realistic because she believed she was big boned.

At 175, she still did not like what she saw. Her upper body was smaller but her thighs and legs looked disproportionate. She decided to keep going until she was happy with what she saw.

Then it became about losing 200 lb total so she could say she lost 200 lb. Then she was in the 140s and wondered if she could get to the 130s. Then she wondered if she could get to 119.

She was weighing herself twice a day. She was saying no to food not because she needed to but because she wanted to keep losing. She realized this was not a healthy relationship with food. This was obsession.

Her body was not okay at 119 lb. She started to look unhealthy. Her blood work was not coming back great. Her doctor sent her to an endocrinologist and a hematologist. They tested her for malabsorption.

It was not malabsorption. It was that her body had never been at that weight before. It went into starvation mode. It takes time for your body to understand and adjust.

That scale and that clothes size can become an obsession when you've been in a larger body for so long and you don't know what it feels like to be in a smaller body.GLP-1 Hub

Why this matters if you haven’t started yet: This is something the trial nutritionist never warned her about. If you are losing rapidly, talk to your doctor about what weight is sustainable for your body.

10. Now she takes between 7.5 and 10 mg and listens to her body

Tara now hovers between 125 and 130 lb. Her clothes fit the same as they did at 119. She thinks the medication is keeping inflammation in check.

She is on compounded tirzepatide and takes somewhere between 7.5 and 10 mg. She has tried microdosing, spacing out, cycling. She has tried semaglutide. She got to her lowest weight on semaglutide.

She has gone months without an injection at all and felt completely fine. The noise creeps back in a little and she has to be more mindful. If it gets to the point where she does not feel in control, she does not admit defeat. She just says her body needs the medication.

Sometimes she will do a weekly injection for a month or two. Sometimes she will go 10 days, a couple weeks, a couple months. The moral of the story is she listens to her body.

One or two pounds does not cause her rings to stop fitting. The inflammation does. She will be back to the point where she cannot get her rings on when it has been a few weeks since her last injection. Her cystic acne will start popping up again, even six years later.

These things exist in her body. They are still there. Her brain did not change. They are controlled with the medication. She has to keep reminding herself of that. It is doing what it is designed to do.

Tara went from a size 26 to a size zero. From shopping in a 3X or 4X to wearing her son's hand-me-down pants. She has been on national television, in the Wall Street Journal, and answered thousands of DMs from strangers who see themselves in her story.

But the part she wants you to know is not the 220 lb she has lost. It is that the medication is not a magic pill. It is a tool. And for her, it is a tool she still needs. Six years later, she is not done. She is just learning what normal looks like.

Questions people ask

What happened to Tara Rothenhoefer after the tirzepatide trial ended?

After losing 132 lb in the 18-month trial, Tara was sent home with no medication and no follow-up. She gained 12 to 15 lb in the year before tirzepatide became available by prescription, even though she was still eating well and exercising. She eventually got back on the medication through a telehealth provider.

What dose of tirzepatide did Tara take in the clinical trial?

Tara's trial started her at 5 mg, then moved to 10 mg, then 15 mg with no titration period. She never received the 2.5 mg starter dose that is now standard when Mounjaro or Zepbound is prescribed commercially.

How much weight has Tara Rothenhoefer lost on tirzepatide?

Tara lost 132 lb during the 18-month trial, starting at 342 lb and getting down to about 210 lb. She continued losing after getting back on medication and eventually got down to 119 lb, which was too low for her body. She now maintains between 125 and 130 lb and has lost more than 220 lb total over six years.

GH
GLP-1 Hub

Tara Rothenhoefer was a participant in the first tirzepatide (Mounjaro) clinical trial in 2020 and has shared her story publicly through national media including the Today Show, Good Morning America, and the Wall Street Journal. She has maintained more than 200 lb of weight loss over six years. 184,104 views on the original video.

Watch the original on YouTube →

Trending Topics

Free, from GLP‑1 Classified

Thinking about a GLP‑1? Read our guide before you start.

The questions to ask, the costs nobody mentions, and what the first month really feels like. Plus a short weekly letter for people on, or considering, a GLP‑1. We are not a pharmacy or a telehealth brand. We work for you, not for them.

No spam. Unsubscribe any time.